Style
GrowthTurnover
Orientation
Concentrated trader| # | Security | Shares | Value | % of Portfolio |
|---|---|---|---|---|
| 1 | Ascendis Pharma A/S(ASND) | 206,234 | $55.0M | 5.72% |
| 2 | Celcuity Inc(CELC) | 500,996 | $52.4M | 5.45% |
| 3 | Cogent Biosciences Inc(COGT) | 1,280,707 | $49.6M | 5.15% |
| 4 | Urogen Pharma LTD(URGN) | 1,301,979 | $47.9M | 4.98% |
| 5 | Immunome Inc(IMNM) | 2,017,009 | $42.7M | 4.44% |
| 6 |
Latest filing, equity positions only
Quarter-over-quarter weight changes
| Sector | Prev % | Curr % | Change |
|---|---|---|---|
| Healthcare | 94.73% | 89.8% | -4.93% |
| Unclassified | 5.27% | 10.2% | +4.93% |
Quarter-over-quarter weight changes by market cap
| Dianthus Therapeutics Inc(DNTH) |
| 390,000 |
| $38.0M |
| 3.95% |
| 7 | Rhythm Pharmaceuticals Inc(RYTM) | 311,461 | $34.6M | 3.59% |
| 8 | Oruka Therapeutics Inc(ORKA) | 352,802 | $33.6M | 3.49% |
| 9 | Monte Rosa Therapeutics Inc(GLUE) | 1,108,295 | $26.8M | 2.79% |
| 10 | Syndax Pharmaceuticals Inc(SNDX) | 1,214,390 | $26.5M | 2.76% |
| Cap Size | Prev % | Curr % | Change |
|---|---|---|---|
| Mid Cap | 57.04% | 46.56% | -10.48% |
| Small Cap | 27.72% | 22.21% | -5.51% |
| Micro Cap | 3.75% | 11.46% | +7.71% |
| Unclassified | 5.27% | 10.2% | +4.93% |
| Large Cap | 6.22% | 9.56% | +3.34% |
Quarter-over-quarter position changes